News | January 13, 2010

Proton Therapy Offers New Specialty for Radiation Therapists

University of Texas M.D. Anderson Cancer Centers Proton Therapy Center.

January 13, 2010 – There is growing awareness about the advantages of proton therapy compared to conventional photon radiation therapy, especially when treating pediatric patients. Protons release most of their energy when they hit the tumor and deliver no exit dose beyond the tumor boundary, unlike photons. This enables the dose to better conform to the tumor and minimizes damage to healthy surrounding tissue, and enabling the radiation oncologist can potentially deliver an even greater dose. This less damaging deliver of dos is especially important when treating children by reducing radiation to growing and developing tissues.

As the proton therapy becomes more prevalent, the first proton-certified radiation therapists (RTTs) in the U.S. received advanced proton therapy certificates was notable. The RTTs earned their certificates at the Ivy Tech Community College-Bloomington program, which provides 16 college credits or the equivalent of two years of continuing education (CE) credits from the American Registry of Radiologic Technologists (ARRT). A portion of the program was held at the ProCure Training and Development Center in Bloomington, a training facility dedicated to proton therapy.

More specialized training in the field will be needed as more proton therapy spring up. Procure, a proton therapy center development company, is currently building a network of proton therapy treatment facilities across the United States. Construction is under way on a ProCure facility in suburban Chicago. Additional centers are in development in suburban Detroit, Mich., South Florida, Seattle, Wash., and Somerset, N.J.

For more information: www.ivytech.edu/bloomington and www.procure.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more